Category: News

Decemer 12, 2020 Edelweiss Immune was highlighted as featured Start-up Biotech in TIDO’s FY19 report

Technology & Innovation Development Office (TIDO) of Boston Children’s Hospital just released its fiscal year 2019 (FY19) annual report on December 12th, 2020. In...

October 6, 2019: Our science broadly posted by professional websites:

Boston Children’s Hospital; Science Daily; Neuroscience News; Eurekalert/AAAS; Dailykos; Healthperiodical; Drug Target Review; Multiple Sclerosis News Today; 21st Century Tech;

September 23, 2019 News about our scientific founders: Targeting a rogue T cell prevents and reverses multiple sclerosis in mice

Multiple sclerosis is an autoimmune disease affecting both adults and children. It’s driven by “helper” T cells, white blood cells that mount an inflammatory attack...